Quick Answer
PRECISION BIOSCIENCES INC reported Total Assets of $154.42 million for the year ending 2025.
- PRECISION BIOSCIENCES INC showed an increase of +13.2% in Total Assets from 2024 to 2025.
- This data is from PRECISION BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $166.80 million | Q2 2019: $271.92 million | Q3 2019: $260.30 million | Q1 2020: $214.20 million | Q2 2020: $184.19 million | Q3 2020: $168.69 million | Q1 2021: $262.32 million | Q2 2021: $230.11 million | Q3 2021: $227.20 million | Q1 2022: $181.35 million | Q2 2022: $297.16 million | Q3 2022: $271.73 million | Q1 2023: $204.50 million | Q2 2023: $181.70 million | Q3 2023: $164.34 million | Q1 2024: $184.74 million | Q2 2024: $165.80 million | Q3 2024: $153.26 million | Q1 2025: $124.41 million | Q2 2025: $108.93 million | Q3 2025: $93.51 million.
- Over the full 8 years of available data (2018 to 2025), PRECISION BIOSCIENCES INC's Total Assets has grown by 11.4%.
- Historical annual values: Fiscal year 2025: $154.42 million | Fiscal year 2024: $136.39 million | Fiscal year 2023: $159.78 million | Fiscal year 2022: $238.17 million | Fiscal year 2021: $211.50 million | Fiscal year 2020: $150.16 million | Fiscal year 2019: $235.23 million | Fiscal year 2018: $138.60 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: